Partner with us
Working Together to
transform Patients’ Lives
We collaborate with like-minded companies innovating with impactful science, focusing on bringing their breakthrough healthcare advancements to the world.
In recent years, there has been a shift in the landscape of New Molecular Entity (NME) approvals by global regulatory agencies. Increasingly a majority of these innovative assets, accelerating patient outcomes, originate from small and mid-size research companies. Provectis aspires to help these companies succeed in a complex landscape, advancing their breakthrough research and accelerating patient-centric outcomes.
Headquartered in Basel, Switzerland, we are an agile and flexible commercial partner with
a partnership network in Europe, Asia, the Middle East, and Oceania.
We partner with biopharmaceutical companies conducting cutting-edge research, fostering long-term relationships, to deliver their trailblazing solutions to patients. Our partners collaborate with us for what we bring to the table and what we call ARC:
We are an agile, nimble, and flexible commercial healthcare company seeking innovative companies to collaborate with to deliver life-changing solutions for patients.People, data, and technology power us. Our complementary pharma expertise, ethical core values, and inclusive culture guide us.
We have a deep geographical reach and a strong partner network in the developing markets of Asia and the Middle East, and the developed market of Europe.Our leadership team brings several years of multi-country, multi-region MNC experience in the pharmaceutical industry. Our headquarters in Basel, Switzerland, affords us extensive knowledge of the area.
From launching innovation and building medical advocacy to undertaking ethical promotion and bringing patient feedback to pioneers, we drive growth for our partners.
Our team brings to the table expertise in global business development and licensing, market access and pricing, launch excellence, government advocacy, competitive readiness, resource planning and financial management, and more.